Medications

Class action against Sanofi wins French court backing

A French court on Wednesday allowed a class-action lawsuit to go ahead against pharmaceutical giant Sanofi by families of victims of Depakine, an epilepsy drug that can severely damage foetal development.

Other

Sanofi to buy US biotech firm Amunix for $1 bn

French pharma giant Sanofi said Tuesday it had signed a billion-dollar deal to buy US-based biotech firm Amunix, which develops cancer treatments that enlist the body's immune system.

Vaccination

Novavax asks EU drug regulator to OK its COVID vaccine

The European Union's drug regulator said it received an application from Novavax to authorize the American biotechnology company's coronavirus vaccine, a request that could significantly boost the continent's vaccine supplies ...

Vaccination

France's Sanofi halts work on mRNA Covid vaccine

French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.

Vaccination

France's Sanofi expands mRNA drive with US firm purchase

France's pharmaceutical giant Sanofi, which has lagged behind rivals in developing new generation mRNA Covid-19 vaccines, on Tuesday said it has purchased a US firm specialising in the technology.

Vaccination

EU agency starts review of France's Sanofi COVID jab

The European Medicines Agency said Tuesday it had started a "rolling review" of France's Sanofi coronavirus jab, which could lead to authorisation for use in the European Union.

Vaccination

France's Sanofi to invest 2 billion euros in mRNA vaccines

French pharmaceutical giant Sanofi said Tuesday that it would invest 2 billion euros ($2.4 billion) in the mRNA vaccine technology behind the pioneering Covid-19 jabs developed by rivals BioNTech-Pfizer and Moderna.

Vaccination

Sanofi, GSK launch final phase of Covid vaccine trials

French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated COVID vaccine as they race to add their jab to the world's arsenal against the pandemic.

Vaccination

Left-behind Sanofi closes in on Covid vaccine

French pharmaceuticals giant Sanofi on Monday reported positive results in trials of its belated Covid-19 jab, raising hopes that France can finally make up lost ground after falling behind in the race to develop a vaccine.

page 2 from 12